- Home
- LOAN vs AVTE Comparison
LOAN vs AVTE Comparison
Compare LOAN & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOAN
- AVTE
- Stock Information
- Founded
- LOAN 1989
- AVTE 2018
- Country
- LOAN United States
- AVTE United States
- Employees
- LOAN N/A
- AVTE N/A
- Industry
- LOAN Real Estate Investment Trusts
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- LOAN Real Estate
- AVTE Health Care
- Exchange
- LOAN Nasdaq
- AVTE Nasdaq
- Market Cap
- LOAN 65.8M
- AVTE 72.5M
- IPO Year
- LOAN 1999
- AVTE 2021
- Fundamental
- Price
- LOAN $5.93
- AVTE $2.51
- Analyst Decision
- LOAN
- AVTE Hold
- Analyst Count
- LOAN 0
- AVTE 7
- Target Price
- LOAN N/A
- AVTE $11.75
- AVG Volume (30 Days)
- LOAN 14.9K
- AVTE 62.3K
- Earning Date
- LOAN 03-12-2025
- AVTE 03-27-2025
- Dividend Yield
- LOAN 7.76%
- AVTE N/A
- EPS Growth
- LOAN 2.37
- AVTE N/A
- EPS
- LOAN 0.49
- AVTE N/A
- Revenue
- LOAN $7,351,609.00
- AVTE N/A
- Revenue This Year
- LOAN N/A
- AVTE N/A
- Revenue Next Year
- LOAN N/A
- AVTE N/A
- P/E Ratio
- LOAN $11.91
- AVTE N/A
- Revenue Growth
- LOAN 1.12
- AVTE N/A
- 52 Week Low
- LOAN $4.89
- AVTE $1.25
- 52 Week High
- LOAN $6.00
- AVTE $32.42
- Technical
- Relative Strength Index (RSI)
- LOAN 67.04
- AVTE 52.00
- Support Level
- LOAN $5.78
- AVTE $2.44
- Resistance Level
- LOAN $5.75
- AVTE $2.56
- Average True Range (ATR)
- LOAN 0.09
- AVTE 0.09
- MACD
- LOAN 0.03
- AVTE 0.00
- Stochastic Oscillator
- LOAN 84.29
- AVTE 77.14
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.